BRCA1 splice variants BRCA1a and BRCA1b associate with CBP co-activator

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 591-595

  Cui, Jian Qi ^a   Shao, Ningsheng ^a   Chai, Yuli ^a   Wang, Huichen ^a   Reddy, E Shyam P ^a   Rao, Veena N ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

BRCA1; CBP co activator; Histone acetyl transferase; Transcription factor acetyl transferase

Indexed keywords

BRCA1 PROTEIN; BRCA1A PROTEIN; BRCA1B PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0031957412     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.3.591     Document Type: Article

References (33)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994.
2. Easton DF, Ford D, Bishop DT and Breast Cancer Linkage Consortium: Breast and ovarian cancer incidence in BRCA1 -mutation carriers. Am J Hum Genet 56: 265-271, 1995.
3. Ford D, Easton DF and Peto J: Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457-1462, 1995.
4. Monteiro AN, August A, Hanafusa H: Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 93: 13595-13599, 1996.
5. Chapman MS and Verrna IM: Transcriptional activation by BRCA1. Nature 382: 678-679, 1996.
6. Milner J, Ponder B, Hughes-Davies L, Seitmann M and Kouzarides T: Transcriptional activation functions in BRCA 2. Nature 386: 772-773, 1997.
7. Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM and Parvin JD: BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 94: 5605-5610, 1997.
8. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK and Lee WH: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791, 1995.
9. Rao VN, Shao N, Ahmad M and Reddy ESP: Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene 12: 523-528, 1996.
10. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schmitt S and Livingston DM: Location of BRCAI in human breast and ovarian cancer cells. Science 272: 123-126, 1996.
11. Wang H, Shao N, Ding QM, Cui JQ, Reddy ESP and Rao VN: BRCAI proteins are transported to the nucleus in the absence of serum and splice variants BRCAI a, BRCAI b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15: 143-157, 1997.
12. Zhang HT, Zhang X, Zhao HZ, Kajino Y, Weber BL, Davis JG, Wang Q, O'Rourke DM, Zhang HB, Kajio K and Green MI: Relationship of p215 BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 14: 2863-2869, 1997.
13. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK and Lee WH: Aberrant subcellular localization of BRCAI in breast cancer. Science 272: 123-126, 1996.
14. Scully R, Chen J, Plug A, Xiao Y, Weaver D, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275, 1997.
15. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY. Bowcock AM and Baer R: Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14: 430-440, 1996.
16. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J and Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425-435, 1997.
17. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC and Jensen RA: Growth retardation and tumor inhibition by BRCA1. Nat Genet 12: 298-302, 1996.
18. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9: 444-450, 1995.
19. Shao N, Chai YL, Reddy ESP and Rao VN: Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13: 1-7, 1996.
20. Takeshima H, Izawa I, Lee PS, Safdar N, Levin VA and Saya H: Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene 9: 2135-2144, 1994.
21. Bannister AJ and Kouzarides T: The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643, 1996.
22. Webster N, Jin JR, Green S, Hollis M and Chambon P: The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52: 169-178, 1988.
23. Nakajima T, Uchida C, Anderson SF, Pavin JD and Montminy M: Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev 11: 738-747, 1997.
24. Janknecht R and Hunter T: Versatile molecular glue. Transcriptional control. Curr Biol 6: 951-954, 1996.
25. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB and Livingston DM: Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8: 869-884, 1994.
26. Bannister AJ and Kouzarides T: CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J 14: 4758-4762, 1995.
27. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y and Collins T: CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94: 2927-2932, 1997.
28. Gu W and Roeder RG: Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606, 1997.
29. Ogryzko VV, Schiltz RL, Russanova V, Howard BH and Nakatani Y: The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959, 1996.
30. Yang XJ, Ogryzko W, Nishikawa J, Howard BH and Nakatani Y: A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 319-324, 1996.
31. Kuo MH, Brownell JE, Sobel RE, Ranalli TA, Cook RG, Edmondson DG. Roth SY and Allis CD: Transcription-linked acetylation by GCN5pp of histone H3 and H4 at specific lysines. Nature 383: 269-272, 1996.
32. Mizzen CA, Yang XJ, Kokubo T, Brownell JE, Bannister AJ, Owen-Hughes T, Workman J, Wang L. Berger SL, Kouzarides T, et al. The TAF 250 subunit of TFID has histone acetyl-transferase activity. Cell 87: 1261-1270, 1996.
33. Rao VN and Reddy ESP: elk-1, a variant of Elk-1, fails to interact with the serum response factor and binds to DNA with modulated specificity. Cancer Res 53: 215-220, 1993.